Evaluate the Pharmacokinetics and Safety Between the Administration of CKD-383 and the Co-administration of CKD-501, D744, and D150
Clinical trial NCT05816759 · COMPLETED
Trial details
- NCT number
- NCT05816759
- Sponsor
- Chong Kun Dang Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-26
- Primary completion
- 2023-06-04
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.